Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2015. Start Trial.
Date Value
November 17, 2026 32.41M
November 16, 2026 32.41M
November 13, 2026 32.31M
November 12, 2026 32.41M
November 11, 2026 33.32M
November 10, 2026 33.92M
November 09, 2026 35.33M
November 06, 2026 38.14M
November 05, 2026 39.25M
November 04, 2026 39.25M
November 03, 2026 37.94M
November 02, 2026 36.63M
October 30, 2026 36.03M
October 29, 2026 37.84M
October 28, 2026 36.23M
October 27, 2026 36.33M
October 26, 2026 38.14M
October 23, 2026 39.25M
October 22, 2026 39.65M
October 21, 2026 41.36M
October 20, 2026 41.46M
October 19, 2026 42.56M
October 16, 2026 42.97M
October 15, 2026 43.67M
October 14, 2026 42.56M
Date Value
October 13, 2026 43.67M
October 12, 2026 45.18M
October 09, 2026 45.48M
October 08, 2026 44.67M
October 07, 2026 45.58M
October 06, 2026 47.39M
October 05, 2026 46.89M
October 02, 2026 47.79M
October 01, 2026 47.69M
September 30, 2026 51.91M
September 29, 2026 75.25M
September 28, 2026 75.64M
September 25, 2026 75.64M
September 24, 2026 76.63M
September 23, 2026 78.30M
September 22, 2026 80.56M
September 21, 2026 81.05M
September 18, 2026 80.36M
September 17, 2026 81.34M
September 16, 2026 82.42M
September 15, 2026 86.26M
September 14, 2026 87.53M
September 11, 2026 90.29M
September 10, 2026 91.17M
September 09, 2026 92.94M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 464.42M
Amgen, Inc. 288.51B
Anika Therapeutics, Inc. 153.30M
BioCryst Pharmaceuticals, Inc. 2.374B
Imunon, Inc. 6.700M